Stock Analiz

CI vs NTRA stock comparison

Cigna vs. Natera · data as of November 13, 2026

Cigna (CI) has a market value of about $78.3B, Natera (NTRA) about $46.3B. Over their latest twelve months Cigna had revenue of $286.3B and Natera $2.9B.

On our five checks Cigna scores higher: 3.2 out of 5 (average) against 1.6 (weak).

By area, the stronger company is Cigna on value; Natera on future growth; Cigna on track record; Natera on financial health; Cigna on shareholder returns.

Cigna leads on 13 of the compared lines and Natera on 5.

Side by side

CINTRA
Size and price
Market cap$78.3B$46.3B
Share price$297.00$319.09
Score
Overall score (of 5)3.21.6
Value40
Future growth34
Track record21
Financial health23
Shareholder returns50
Valuation
P/E (TTM)13.1—
Forward P/E9.2—
Price / free cash flow9.5881.9
Price / sales0.315.9
EV / EBITDA8.1—
PEG——
DCF value vs. price+98%−94%
Business
Revenue$286.3B$2.9B
Net income$6.0B-$165M
Free cash flow$8.3B$52M
Net margin2.1%-5.7%
Gross margin (5-yr avg.)28.5%—
ROIC (5-yr avg.)9.4%-26.7%
Growth
Revenue growth (1 yr)11.2%35.9%
Revenue growth (5 yrs, per year)11.4%42.6%
EPS growth (5 yrs, per year)-0.7%—
Balance sheet and payouts
Net cash (cash minus debt)-$23.8B—
Dividend yield2.10%None
Shareholder yield6.7%0.0%
Analysts
Upside to average target+16%+29%
Consensus ratingBuyStrong buy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: CI TTM to September 30, 2026, NTRA TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Cigna or Natera?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Cigna scores 3.2 out of 5 and Natera 1.6; the table shows where each one is stronger.

Which grows faster, Cigna or Natera?

Over five years Natera grew revenue about 42.6% a year and Cigna about 11.4% a year.

Which pays a higher dividend?

Cigna yields 2.10% and Natera nothing (no dividend).

Full Cigna analysis → Full Natera analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.